The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Clinical Investigation

• Publication date

  2004-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI18838PMID 15124024PMCID PMC398424
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Major histocompatibility complex class I molecules

  2004cited by this paper
• Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease.

  2003cited by this paper
• The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan

  2003cited by this paper
• The MHC Class I-Like IgG Receptor Controls Perinatal IgG Transport, IgG Homeostasis, and Fate of IgG-Fc-Coupled Drugs1

  2003cited by this paper
• Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis.

  2003cited by this paper
• IVIG induces dose-dependent amelioration of ITP in rodent models.

  2003cited by this paper
• The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases.

  2002cited by this paper
• Critical Roles for Interleukin 1 and Tumor Necrosis Factor α in Antibody-induced Arthritis

  2002cited by this paper
• Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia.

  2002cited by this paper
• Intravenous Immunoglobulin Mediates an Increase in Anti-Platelet Antibody Clearance via the FcRn Receptor

  2002cited by this paper
• Arthritis critically dependent on innate immune system players.

  2002cited by this paper
• How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease

  2002cited by this paper
• Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease.

  2002cited by this paper
• The role of FcgammaR signaling in the K/B x N serum transfer model of arthritis.

  2002cited by this paper
• Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis

  2002cited by this paper
• Dynamic visualization of a joint-specific autoimmune response through positron emission tomography

  2002cited by this paper
• Roles of Fc receptors in autoimmunity

  2002cited by this paper
• The Role of FcγR Signaling in the K/B × N Serum Transfer Model of Arthritis1

  2002cited by this paper
• Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.

  2001cited by this paper
• UvA-DARE ( Digital Academic Repository ) Accelerated autoantibody clearance by intravenous immunoglobulin therapy : studies in experimental models to determine the magnitude and time course of the effect

  2001cited by this paper
• Deficiency in β2-Microglobulin, But Not CD1, Accelerates Spontaneous Lupus Skin Disease While Inhibiting Nephritis in MRL-Faslpr Mice: An Example of Disease Regulation at the Organ Level1

  2001cited by this paper
• Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype.

  2001cited by this paper
• Rheumatoid arthritis.

  2001cited by this paper
• Essential Role of Neutrophils in the Initiation and Progression of a Murine Model of Rheumatoid Arthritis1

  2001cited by this paper
• Multiple roles for the major histocompatibility complex class I- related receptor FcRn.

  2000cited by this paper
• A revival of the B cell paradigm for rheumatoid arthritis pathogenesis?

  2000cited by this paper
• Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases.

  1999cited by this paper
• From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins.

  1999cited by this paper
• Supply, use, and abuse of intravenous immunoglobulin.

  1999cited by this paper
• Intravenous immunoglobulins and transforming growth factor β

  1998cited by this paper
• Mechanism of Action of Intravenous Immunoglobulin and Therapeutic Considerations in the Treatment of Autoimmune Neurologic Diseases

  1998cited by this paper
• Intravenous immunoglobulins and transforming growth factor beta.

  1998cited by this paper
• IgG biosynthesis: no "immunoregulatory feedback".

  1997cited by this paper
• Beta 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism.

  1997cited by this paper
• Augmented humoral and anaphylactic responses in FcγRII-deficient mice

  1996cited by this paper
• beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice.

  1996cited by this paper
• Mechanisms of action of intravenous immune globulin in immune‐mediated diseases

  1996cited by this paper
• Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice.

  1996cited by this paper
• Organ-specific disease provoked by systemic autoimmunity.

  1996cited by this paper
• Defective iron homeostasis in beta 2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man

  1996cited by this paper
• Reduced development of CD4−8−B220+ T cells but normal autoantibody production in lpr/lpr mice lacking major histocompatibility complex class I molecules

  1995cited by this paper
• Decreased CD4-CD8- TCR-alpha beta + cells in lpr/lpr mice lacking beta 2-microglobulin.

  1995cited by this paper
• Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I

  1995cited by this paper
• MHC class I-deficient mice.

  1994cited by this paper
• Effect of MHC class I and CD8 cell deficiency on experimental autoimmune myasthenia gravis pathogenesis.

  1994cited by this paper
• Elimination of infectious antigens and increase of IgG catabolism as possible modes of action of IVIg.

  1993cited by this paper
• Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus.

  1993cited by this paper
• An Fc receptor structurally related to MHC class I antigens

  1989cited by this paper
• The role of cell-surface receptors in the transport and catabolism of immunoglobulins.

  1972cited by this paper

• Effectiveness of Maternal Respiratory Syncytial Virus Vaccination in Conferring Infant Immunity: Review and Future Perspectives

  2026cites this paper
• Immunoglobulin therapy for the fetus and neonate

  2026cites this paper
• Neonatal Fc Receptor - Biology and Therapeutics.

  2025cites this paper
• Rituximab combined with intravenous immunoglobulin in autoimmune diseases: a systematic review

  2025cites this paper
• Efgartigimod as rescue treatment in acute phase of neuromyelitis optica spectrum disorder: A Case Report

  2024cites this paper
• Immunomodulatory and anti‐inflammatory properties of immunoglobulin G antibodies

  2024cites this paper
• Immunoglobulins: Mechanistic Approaches in Moderation of Various Inflammatory and Anti-Inflammatory Pathways.

  2024cites this paper
• Albumin influences leucocyte FcRn expression in the early days of kidney transplantation

  2024cites this paper
• Impact of Infections During Pregnancy on Transplacental Antibody Transfer

  2024cites this paper
• Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine

  2023influential citation
• Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation

  2023cites this paper
• Neonatal Fc Receptor Inhibitor Therapeutics in Neuromuscular Disease.

  2023cites this paper
• Intravenous Immunoglobulin: Mechanism of Action in Autoimmune and Inflammatory Conditions.

  2023cites this paper
• Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on Sialylation

  2023cites this paper
• Efgartigimod alfa for the treatment of primary immune thrombocytopenia

  2023cites this paper
• The therapeutic age of the neonatal Fc receptor

  2023cites this paper
• Convalescent plasma in COVID-19: renewed focus on the timing and effectiveness of an old therapy

  2022cites this paper
• “Ways in which the neonatal Fc-receptor is involved in autoimmunity”

  2021cites this paper
• Cellular and Molecular Crosstalk of Graft Endothelial Cells During AMR: Effector Functions and Mechanisms

  2021cites this paper
• Convalescent plasma in Covid-19: Possible mechanisms of action

  2020cites this paper
• N‐glycosylated IgG in patients with kidney transplants increases calcium/calmodulin kinase IV in podocytes and causes injury

  2020cites this paper
• Neonatal Fc receptor expression in lymphoid and myeloid cells in systemic lupus erythematosus

  2020cites this paper
• Engineering of Fc Multimers as a Protein Therapy for Autoimmune Disease

  2020influential citation
• Knockout of the neonatal Fc Receptor (FcRn) in cultured podocytes alters IL-6 signaling and the actin cytoskeleton.

  2019cites this paper
• Anti-inflammatory activity of intravenous immunoglobulin through scavenging of heme

  2019cites this paper
• Natural Antibodies: from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis

  2019cites this paper
• The Neonatal Fc Receptor (FcRn): A Misnomer?

  2019cites this paper
• The use of IVIg in fetal and neonatal alloimmune thrombocytopenia- Principles and mechanisms.

  2019cites this paper
• Treatment of pemphigus vulgaris: part 2 – emerging therapies

  2019cites this paper
• Human cytomegalovirus evades antibody-mediated immunity through endoplasmic reticulum-associated degradation of the FcRn receptor

  2019cites this paper
• Anti-inflammatory Activity of IgG-Fc.

  2019cites this paper
• Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex–mediated immune responses

  2019cites this paper
• Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effects of FcRn Inhibitors in Mice, Rats, and Monkeys.

  2019cites this paper
• Unidirectional transport of IgG by neonatal Fc receptor in human thyrocytes varies across different IgG subclasses.

  2018cites this paper
• In vivo depletion of serum IgG by an affibody molecule binding the neonatal Fc receptor

  2018cites this paper
• Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration

  2018cites this paper
• Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues

  2018cites this paper
• Role of Intravenous Immunoglobulin in Dermatologic Disorders

  2018cites this paper
• Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile

  2018cites this paper
• Kill 'Em All: Efgartigimod Immunotherapy for Autoimmune Diseases.

  2018cites this paper
• Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMR

  2018cites this paper
• Structural basis for pH-insensitive inhibition of immunoglobulin G recycling by an anti-neonatal Fc receptor antibody

  2017influential citation
• IVIG-mediated effector functions in autoimmune and inflammatory diseases

  2017cites this paper
• Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology

  2016cites this paper
• The Effect of High Carbohydrate Consumption on Glucose Levels and Antibody Production in Nonobese Diabetic Mice

  2016cites this paper
• Immunomodulation of immunothrombocytopenia.

  2016cites this paper
• Mouse and human FcR effector functions

  2015cites this paper
• Fully Human Monoclonal Antibody Inhibitors of the Neonatal Fc Receptor Reduce Circulating IgG in Non-Human Primates

  2015cites this paper
• Analysis of Response Elements Involved in the Regulation of the Human Neonatal Fc Receptor Gene (FCGRT)

  2015influential citation
• The multiple facets of FcRn in immunity

  2015cites this paper
• The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy.

  2015cites this paper
• Engineering Ameliorates Arthritis in a Neonatal Fc Receptor Blockade by Fc

  2015influential citation
• Assessments of antibody biodistribution

  2015cites this paper
• Evaluation of synovial mast cell functions in autoimmune arthritis.

  2015cites this paper
• Regulation of Immune Responses by the Neonatal Fc Receptor and Its Therapeutic Implications

  2015cites this paper
• Neonatal Fc receptor promotes immune complex-mediated glomerular disease.

  2014cites this paper
• Targeting the Fc receptor in autoimmune disease

  2014cites this paper
• Genetically Engineered Humanized Mouse Models for Preclinical Antibody Studies

  2014cites this paper
• The function of Fcγ receptors in dendritic cells and macrophages

  2014cites this paper
• Current Pathways for Immune Manipulation

  2014cites this paper
• Targeting FcRn for therapy: from live cell imaging to in vivo studies in mice.

  2014cites this paper
• The regulation of CD8 T cell responses by inflammatory cytokines and FcgammaRIIB

  2014cites this paper
• Immunity and Tolerance in the K/BxN Model of Spontaneous Arthritis and Endocarditis

  2013cites this paper
• Discovery and structure-activity relationships of small molecules that block the human immunoglobulin G-human neonatal Fc receptor (hIgG-hFcRn) protein-protein interaction.

  2013cites this paper
• Molecular and Cellular Mechanisms of Antibody Activity

  2013cites this paper
• SR-A) Influences B Cell Autoimmunity by Macrophage Scavenger Receptor 1 (Msr1,

  2013cites this paper
• Development of Autoimmune Diabetes in Receptors Participate in the γ Activating Fc

  2013cites this paper
• Regulation of Immunological Responses by the Neonatal Fc Receptor for IgG, FcRn

  2013cites this paper
• Investigation of the role of FcγR and FcRn in mAb distribution to the brain.

  2013cites this paper
• Contribution of Renal and Non‐Renal Clearance on Increased Total Clearance of Adalimumab in Glomerular Disease

  2013cites this paper
• Macrophage Scavenger Receptor 1 (Msr1, SR-A) Influences B Cell Autoimmunity by Regulating Soluble Autoantigen Concentration

  2013cites this paper
• Concentration Regulating Soluble Autoantigen SRA ) Influences B Cell Autoimmunity by Macrophage Scavenger Receptor 1 ( Msr 1

  2013cites this paper
• Platelets in Inflammation and Immune Modulations: Functions Beyond Hemostasis

  2012cites this paper
• Polarised Transfer of Proteins Through the Syncytiotrophobalst and Tissue Culture Cell Lines

  2012cites this paper
• Biology of Gut Immunoglobulins

  2012cites this paper
• Identification and Characterization of the Receptor for the Soluble Fibrinogen Like Protein 2 (FGL2)

  2012cites this paper
• Development of Antibody-Based Therapeutics

  2012cites this paper
• The Biology of the Neonatal Fc Receptor (FcRn)

  2012cites this paper
• Mécanismes d'action des immunoglobulines.

  2012cites this paper
• The Diverse Roles of FcRn: Implications for Antibody Engineering

  2012cites this paper
• Application of knockout mouse models to investigate the influence of FcγR on the tissue distribution and elimination of 8C2, a murine IgG1 monoclonal antibody.

  2012cites this paper
• Properties of mouse and human IgG receptors and their contribution to disease models.

  2012cites this paper
• The Immunologic Functions of the Neonatal Fc Receptor for IgG

  2012cites this paper
• Intervenous immunoglobulins as modulators of immune response : effect on T cell polarisation, pathogenicity and trafficking

  2012cites this paper
• Mechanisms of Disease Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases

  2012cites this paper
• Intravenous immune globulin in autoimmune and inflammatory diseases.

  2012cites this paper
• Application of Antibody Engineering in the Development of Next Generation Antibody-Based Therapeutics

  2012cites this paper
• [Mechanisms of action of intravenous immunoglobulins].

  2012cites this paper
• Monoclonal antibodies directed against human FcRn and their applications

  2012cites this paper
• B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo

  2012cites this paper
• Systemic Lupus Erythematosus MHC Class I Family Proteins Retard Roopenian

  2011cites this paper
• RIIIA-Dependent Mechanisms g Airway Inflammation through Fc Invariant NKT Cell-Mediated Allergic Cutting Edge: Intravenous Ig Inhibits

  2011cites this paper
• The Paf oncogene is essential for hematopoietic stem cell function and development

  2011cites this paper
• Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8−CD11b+ dendritic cells

  2011cites this paper
• Pharmacokinetics of Immunoglobulin G and Serum Albumin: Impact of the Neonatal Fc Receptor on Drug Design

  2011cites this paper
• The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia.

  2011cites this paper
• Chlamydia muridarum Major Outer Membrane Protein‐Specific Antibodies Inhibit In Vitro Infection but Enhance Pathology In Vivo

  2011cites this paper
• Cutting Edge: Intravenous Ig Inhibits Invariant NKT Cell-Mediated Allergic Airway Inflammation through FcγRIIIA-Dependent Mechanisms

  2011cites this paper
• Cutting Edge: The Murine High-Affinity IgG Receptor FcγRIV Is Sufficient for Autoantibody-Induced Arthritis

  2011cites this paper
• Neonatal Fc Receptor Blockade by Fc Engineering Ameliorates Arthritis in a Murine Model

  2011influential citation